MedPath

Pharmaceutical Companies

Lifecore Biomedical

🇺🇸United States
Ownership
-
Established
-
Employees
484
Market Cap
$146.4M
Website
-
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the...
Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

🇺🇸United States
Ownership
Public
Established
2014-01-01
Employees
384
Market Cap
$145M
Website
http://www.amylyx.com
Ownership
Public
Established
2005-01-01
Employees
59
Market Cap
$141.7M
Website
http://www.atyrpharma.com
INmune Bio Inc. logo

INmune Bio Inc.

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$139.6M
Website
-

Kodiak Sciences

🇺🇸United States
Ownership
-
Established
-
Employees
111
Market Cap
$138.9M
Website
-
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for...

CervoMed

🇺🇸United States
Ownership
-
Established
-
Employees
8
Market Cap
$137.5M
Website
-
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing...
Vigil Neuroscience logo

Vigil Neuroscience

🇺🇸United States
Ownership
Public
Established
2020-01-01
Employees
69
Market Cap
$137.1M
Website
http://www.vigilneuro.com
Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of...

Adagene AG

🇨🇭Switzerland
Ownership
-
Established
-
Employees
-
Market Cap
$133.2M
Website
-
ALX Oncology logo

ALX Oncology

🇺🇸United States
Ownership
Public, Subsidiary
Established
2015-01-01
Employees
72
Market Cap
$131.1M
Website
http://www.alxoncology.com
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic...

INVENTIVA

🇲🇦Morocco
Ownership
-
Established
-
Employees
-
Market Cap
$130.6M
Website
-
© Copyright 2025. All Rights Reserved by MedPath